Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bavarian Nordic A/S (BVNKF)

Bavarian Nordic A/S (BVNKF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bavarian Nordic A/S

Description:

Bavarian Nordic AS was established in 1994. The Company is a biotechnology company that specializes in the production of vaccines for the treatment of biodefense, cancer, and infectious diseases. Its business is divided into two segments: Cancer Immunotherapy and Infectious Diseases. In Cancer Immunotherapy, the Company is developing PROSTVAC AND CV-301 for the treatment of patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. In Infectious Diseases, the U.S. Government awarded contracts for the development and supply of IMVAMUNE, including awards to advance MVA-BN. IMVANEX/IMVAMUNE treats patients with smallpox diseases. In the U.S., the Company develops IMVAMUNE as a non-replicating smallpox vaccine suitable for individuals who are not recommended to receive conventional replicating smallpox vaccines, such as patients with HIV, patients with AD and members of their household. The development is funded by the U.S. Government, through contracts with BARDA and NIH. The company operates in Denmark, Germany, the United States, and Singapore.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 3.52%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BVNKF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00
Net Margin % -0.10
Debt/Equity 0.09
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.28
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar